Becton, Dickinson and Co (NYSE:BDXB.PFD)
$ 48.16 0.66 (1.39%) Market Cap: - Enterprise Value: - PE Ratio: 48.87 PB Ratio: 2.65 GF Score: 79/100

Becton Dickinson and Co at Bank of America Global Healthcare Conference Transcript

May 09, 2023 / 03:00PM GMT
Release Date Price: $50.07 (-0.14%)
Travis Lee Steed
BofA Securities, Research Division - MD

Good morning, everybody. Travis Steed, medical device analyst at Bank of America. And we're kicking off the conference officially with Becton, Dickinson. We have Chris, CFO, obviously; and then Michael Garrison, Head of the -- I guess, the Medical division, right?

Michael Garrison
Becton, Dickinson and Company - Executive VP & President of Medical segment

That's right.

Travis Lee Steed
BofA Securities, Research Division - MD

Medical division? Correct.

Questions & Answers

Travis Lee Steed
BofA Securities, Research Division - MD

So I guess to start off, just reported Q1 a couple of days ago -- or Q2, fiscal Q2, and strong quarter. Revenues came in a little bit ahead. And maybe just to level set us on the revenue kind of some of the things that you saw the strength in the quarter, you can start total company, and then maybe you can talk about the Medical division. And I guess, kind of curious how

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot